Exhibit 10.34
ASSET PURCHASE
AGREEMENT
BETWEEN
NEUROMED DEVELOPMENT INC.
AND
MALLINCKRODT INC.
Dated as of June 11,
2009
Portions of this Exhibit were omitted and have
been filed separately with the Secretary of the Commission pursuant
to the Company’s application requesting confidential
treatment under Rule 406 promulgated under the Securities Act of
1933, as amended; [*] denotes omissions.
This Asset Purchase Agreement
(the “Agreement”) contains representations and
warranties that Neuromed Development Inc. (“Neuromed”)
and Mallinckrodt Inc. (“Mallinckrodt”) made to each
other. These representations and warranties were made only for the
purposes of the Agreement and solely for the benefit of Neuromed
and Mallinckrodt as of specific dates, may be subject to important
limitations and qualifications agreed to by the parties thereto and
included in confidential disclosure schedules provided by Neuromed
and Mallinckrodt to each other in connection with the signing of
the Agreement, and may not be complete. Furthermore, these
representations and warranties may have been made for the purposes
of allocating contractual risk between Neuromed and Mallinckrodt
instead of establishing these matters as facts, and may or may not
have been accurate as of any specific date and do not purport to be
accurate as of the date of the filing of the Agreement by
CombinatoRx, Incorporated with the Securities and Exchange
Commission. Accordingly, you should not rely upon the
representations and warranties contained in the Agreement as
characterizations of the actual state of facts, since they were
intended to be for the benefit of, and to be limited to, the
parties thereto.
T ABLE OF C ONTENTS
|
|
|
|
|
|
ARTICLE I
|
|
DEFINITIONS;
RULES OF CONSTRUCTION
|
|
1
|
|
SECTION 1.1
|
|
Definitions
|
|
1
|
|
SECTION 1.2
|
|
Rules
of Construction
|
|
1
|
|
ARTICLE II
|
|
SALE OF ASSETS;
ASSUMPTION OF LIABILITIES; CONSIDERATION; CLOSING
|
|
2
|
|
SECTION 2.1
|
|
Transfer
of Assets
|
|
2
|
|
SECTION 2.2
|
|
Assignability
and Consents
|
|
2
|
|
SECTION 2.3
|
|
Liabilities
|
|
3
|
|
SECTION 2.4
|
|
Consideration
|
|
5
|
|
SECTION 2.5
|
|
Closing
|
|
6
|
|
SECTION 2.6
|
|
Closing
Deliveries by Seller
|
|
7
|
|
SECTION 2.7
|
|
Closing
Deliveries by Purchaser
|
|
7
|
|
SECTION 2.8
|
|
Further
Deliveries by Seller
|
|
7
|
|
SECTION 2.9
|
|
Agreements
Relating to Electronic Transfer and Physical Delivery of
Transferred Assets
|
|
7
|
|
ARTICLE III
|
|
REPRESENTATIONS
AND WARRANTIES OF SELLER
|
|
8
|
|
ARTICLE IV
|
|
REPRESENTATIONS
AND WARRANTIES OF PURCHASER
|
|
8
|
|
ARTICLE V
|
|
ADDITIONAL
AGREEMENTS
|
|
9
|
|
SECTION 5.1
|
|
NDA
Transfer
|
|
9
|
|
SECTION 5.2
|
|
Diligence
|
|
9
|
|
SECTION 5.3
|
|
Audits
|
|
9
|
|
SECTION 5.4
|
|
Confidentiality
|
|
10
|
|
SECTION 5.5
|
|
Tax
Matters
|
|
12
|
|
SECTION 5.6
|
|
Regulatory
Matters
|
|
13
|
|
SECTION 5.7
|
|
Royalty-Related
Rights and Obligations
|
|
13
|
|
SECTION 5.8
|
|
Further
Assurance
|
|
14
|
|
ARTICLE VI
|
|
CONDITIONS TO
CLOSING
|
|
14
|
|
SECTION 6.1
|
|
Conditions
to Obligations of Seller
|
|
14
|
|
SECTION 6.2
|
|
Conditions
to Obligations of Purchaser
|
|
15
|
i
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
|
|
|
|
|
|
ARTICLE VII
|
|
INDEMNIFICATION
|
|
16
|
|
SECTION 7.1
|
|
Survival
of Representations and Warranties and Covenants
|
|
16
|
T ABLE OF C ONTENTS
(Continued)
|
|
|
|
|
|
SECTION 7.2
|
|
Indemnification
|
|
16
|
|
ARTICLE VIII
|
|
MISCELLANEOUS
|
|
20
|
|
SECTION 8.1
|
|
Governing
Law
|
|
20
|
|
SECTION 8.2
|
|
Venue
|
|
20
|
|
SECTION 8.3
|
|
Amendment
|
|
20
|
|
SECTION 8.4
|
|
Expenses
|
|
20
|
|
SECTION 8.5
|
|
Notices
|
|
21
|
|
SECTION 8.6
|
|
Severability
|
|
23
|
|
SECTION 8.7
|
|
Entire
Agreement
|
|
23
|
|
SECTION 8.8
|
|
Assignment
|
|
23
|
|
SECTION 8.9
|
|
Delays
or Omissions
|
|
23
|
|
SECTION 8.10
|
|
No
Third Party Beneficiaries
|
|
24
|
|
SECTION 8.11
|
|
Counterparts
|
|
24
|
|
SECTION 8.12
|
|
Specific
Performance
|
|
24
|
|
SECTION 8.13
|
|
WAIVER
OF JURY TRIAL
|
|
24
|
ii
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
EXHIBITS
|
|
|
|
Exhibit A
|
|
Definitions and
References
|
|
Exhibit B
|
|
Transferred
Tangible and Intangible Assets
|
|
Exhibit C
|
|
Transferred
Contracts
|
|
Exhibit D
|
|
Royalties
|
|
Exhibit E
|
|
Representations
and Warranties of Seller
|
|
Exhibit F
|
|
Assumed
Development Cost Liabilities
|
|
Exhibit G
|
|
Reimbursed
Development Costs
|
|
Exhibit H
|
|
Representations
and Warranties of Purchaser
|
|
Exhibit I
|
|
Assignment and
Assumption Agreement
|
|
Exhibit J
|
|
Bill of
Sale
|
|
Exhibit K
|
|
Development and
Transition Services Agreement
|
|
Exhibit L
|
|
Guaranty of
Covidien International Finance S.A.
|
|
Exhibit M
|
|
Guaranty of
NPL
|
i
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
ASSET PURCHASE
AGREEMENT
This Asset Purchase
Agreement (the “
Agreement ”) is made as of June 11, 2009 between
Neuromed Development Inc., a corporation organized under the laws
of Barbados (“ Seller ”) and Mallinckrodt Inc.,
a Delaware corporation and an indirect subsidiary of Covidien Ltd.
(“ Purchaser ”). Purchaser and Seller may each
be referred to herein as a “ Party ” and
collectively as the “ Parties .”
RECITALS
A. Seller has certain rights to the
Products.
B. Purchaser desires to purchase and
acquire, and Seller desires to sell and transfer to Purchaser
Seller’s rights to all of its tangible and intangible assets
related to the Products, including assuming certain contracts
related to the Products, subject to the terms and conditions of
this Agreement.
Now, therefore, in consideration of
the foregoing premises, the mutual representations, warranties,
covenants and other agreements set forth herein and the mutual
benefits to be gained by the performance thereof, and for other
good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged and accepted, the Parties hereby
agree as follows:
ARTICLE I
DEFINITIONS; RULES OF
CONSTRUCTION
SECTION 1.1
Definitions .
Capitalized terms used in this Agreement are defined on
Exhibit A . Exhibit A also contains
references to terms defined in the body of this Agreement and other
Exhibits to this Agreement.
SECTION 1.2 Rules of
Construction . When a
reference is made in this Agreement to an Article, Section or
Exhibit, such reference shall be to an Article or Section of, or
Exhibit to, this Agreement unless otherwise indicated. The words
“include,” “includes” and
“including” when used herein shall be deemed in each
case to be followed by the words “without limitation.”
The terms “hereof,” “herein,”
“hereby” and derivative or similar words refer to this
entire Agreement. The headings set forth in this Agreement are for
reference purposes only and shall not affect in any way the meaning
or interpretation of this Agreement. All references in this
Agreement to the Subsidiaries of a Party shall be deemed to include
all direct and indirect Subsidiaries of such Party. Unless
otherwise specifically provided, all references in this Agreement
to monetary amounts or dollars shall mean and refer to United
States Dollars. The Parties agree that they have been represented
by legal counsel during the negotiation and execution of this
Agreement and, therefore, waive the application of any law,
regulation, holding or rule of construction providing that
ambiguities in an agreement or other document shall be construed
against the party drafting such agreement or document.
1
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
ARTICLE II
SALE OF ASSETS; ASSUMPTION
OF
LIABILITIES; CONSIDERATION;
CLOSING
SECTION 2.1 Transfer of
Assets . Upon the
terms and subject to the conditions set forth in this Agreement,
which is entered into simultaneously with the Closing of the
transactions contemplated hereunder, Seller hereby conveys, assigns
and transfers to Purchaser, and Purchaser hereby acquires from
Seller, free and clear of any Encumbrances (other than Encumbrances
arising expressly under the Transferred Contracts), all of
Seller’s right, title and interest in and to the following
assets (collectively, the “ Transferred Assets
”):
(a) the Transferred Tangible and
Intangible Assets;
(b) the Transferred Contracts;
and
(c) all rights, claims, causes of
action and credits, including all guarantees, warranties,
indemnities, rights of set-off and similar rights, in favor of
Seller to the extent relating to any of the foregoing Transferred
Assets or any Assumed Liability, other than such rights, claims,
causes of action and credits to the extent relating to any Retained
Liability, including all causes of action for past misappropriation
or infringement of any Transferred Asset and rights to damages and
other remedies for past misappropriation or infringement of any
Transferred Asset.
Except as set forth on Exhibit
E , the Transferred Assets are being assigned, transferred and
conveyed to Purchaser with no other representations or warranties,
including those pertaining to merchantability or fitness or
use.
The transfer of the Transferred
Assets pursuant to this Agreement shall not include the assumption
of any Liability related to the Transferred Assets that arose
(including payments that became due) prior to the Effective Time
unless Purchaser expressly assumes that Liability pursuant to
Section 2.3(a).
SECTION 2.2 Assignability and
Consents .
Notwithstanding anything to the contrary contained in this
Agreement and subject to the Parties’ rights under Article
VI, if the conveyance, assignment, transfer or delivery or
attempted conveyance, assignment, transfer or delivery to Purchaser
of any Transferred Asset is (a) prohibited by any applicable
Law or (b) would require any authorizations, approvals,
consents or waivers from a third party to convey, assign, transfer
or deliver such Transferred Asset and such authorizations,
approvals, consents or waivers have not been obtained prior to the
Closing Date (each, a “ Non-Assignable Asset ”),
in either case, the Closing shall not proceed without the express
consent of Purchaser that any such Non-Assignable Asset may be
transferred by Seller after the Closing. If, in the event of such
consent from Purchaser, the Closing proceeds, the Closing shall not
constitute the conveyance, assignment, transfer or delivery of such
Non-Assignable Asset, and this Agreement shall not constitute a
conveyance, assignment, transfer or delivery of such Non-Assignable
Asset
2
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
unless and until such authorization, approval,
consent or waiver is obtained. After the Closing, the Parties shall
continue to use their best reasonable efforts and cooperate with
each other, without the payment of additional consideration by
Purchaser or Seller to effect the assignment of such Non-Assignable
Asset, to obtain any such authorization, approval, consent or
waiver as promptly as practicable, and it is understood that Seller
shall reimburse Purchaser for any reasonable out-of-pocket expenses
incurred in connection with such efforts to the extent Seller and
Purchaser agree that any such expenditure is reasonably necessary
to effect the transfer of any Non-Assignable Asset. Once
authorization, approval or waiver of or consent for the conveyance,
assignment, transfer or delivery of any such Non-Assignable Asset
not conveyed, assigned, transferred or delivered at the Closing is
obtained, Seller shall convey, assign, transfer and deliver to
Purchaser all of Seller’s right, title and interest in and to
such Non-Assignable Asset at no additional cost to Purchaser. In
addition, for so long as a Transferred Contract remains a
Non-Assignable Asset, Seller agrees to cooperate with Purchaser, as
reasonably requested in writing by Purchaser, to extend and make
available to Purchaser any rights and/or benefits available under
such contract, provided that Purchaser pays all amounts and
fulfills all obligations arising from or associated with such
Non-Assignable Assets, other than to the extent such amounts or
obligations would constitute a Retained Liability if such
Non-Assignable Asset were conveyed, assigned, transferred or
delivered on the Closing Date and other than such amounts and
obligations that arise as a consequence of the fact that such
Non-Assignable Asset could not be transferred at the Closing.
Without limiting the foregoing, (a) upon the written request
of Purchaser, Seller agrees to exercise rights (for example,
elections or options) on Purchaser’s behalf under such
contract, at Purchaser’s expense, provided that all
Liabilities resulting from the exercise of such rights shall be
Liabilities solely of Purchaser, and Seller shall not exercise any
of its rights under such contract unless requested or approved in
writing by Purchaser, (b) Seller shall keep Purchaser informed
as to Seller’s written communications from the other party to
such contract, including notifying Purchaser in the event Seller is
notified with respect to matters that require Seller’s
consent (or which trigger an option or an election by Seller) under
such contract, or regarding matters that affect Seller’s or
Purchaser’s rights thereunder, (c) to the extent that
Purchaser obtains the agreement of the other party to such contract
to modify, amend or otherwise alter or waive any performance,
obligation or provision of such contract, Seller agrees to take
such actions and execute such documents as Purchaser may reasonably
request in writing to effect the same, at Purchaser’s
expense, provided that all Liabilities resulting from such
modification, amendment, alteration or waiver shall be Liabilities
solely of Purchaser and (d) in the event that Purchaser
obtains an agreement from the other party to such contract to
transfer the rights under such contract directly to Purchaser,
Seller shall transfer such rights to Purchaser in a writing
reasonably acceptable to Purchaser.
SECTION 2.3
Liabilities.
(a) Assumed Liabilities . On
the Closing Date, Purchaser shall assume and agree to discharge
only (i) Liabilities arising from and after the Effective Time
under any Transferred Contract, including all payments due after
the Effective Time, but excluding any Liability to the extent
arising out of, or relating to, a breach of a Transferred Contract
that occurred prior to the Effective Time, (ii) any Liability
for Taxes attributable to the Transferred
3
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
Assets for any Post-Closing Tax
Period, (iii) all Liabilities related to the Products or the
ownership of the Transferred Assets arising from and after the
Effective Time except as provided in and subject to any obligations
set forth in the Development and Transition Services Agreement and
(iv) the Assumed Development Cost Liabilities (collectively,
the “ Assumed Liabilities ”). It is understood
that in no event will Purchaser or any of its Affiliates be
required to reimburse Seller or any of its Affiliates in an amount
in excess of $16,000,000 in the aggregate for (A) Assumed
Development Cost Liabilities; (B) all amounts that are paid to
Seller for Reimbursed Development Costs and (C) for all
amounts that will be paid for Development of Products under and
pursuant to the Development and Transition Services Agreement,
notwithstanding the amount of any Liabilities that may be described
on Exhibit F and except as otherwise provided in
Section 2.4 of the Development and Transition Services
Agreement. Except as expressly provided in this Section 2.3,
none of Purchaser or any of its Affiliates will be deemed for any
reason to have become liable for or successor to any other
liabilities or obligations, liquidated or unliquidated, known or
unknown, of Seller or any of its Affiliates or
successors.
(b) Retained Liabilities .
All Liabilities of Seller other than the Assumed Liabilities (the
“ Retained Liabilities ”) shall remain the sole
responsibility of Seller. For the avoidance of doubt, the Retained
Liabilities shall include:
(i) any Liability of Seller under
any Transferred Contract that arises after the Effective Time to
the extent arising out of or relating to any breach thereof that
occurred prior to the Effective Time;
(ii) any Liabilities of Seller, or
any member of any consolidated, affiliated, combined or unitary
group of corporations of which Seller or any of its Affiliates is
or has been a member, for Taxes attributable to the Transferred
Assets, including any Liability for Taxes resulting from or arising
out of any transactions contemplated in this Agreement, for any Pre
Closing Tax Period;
(iii) any Liabilities of Seller
arising out of any product liability, patent infringement, breach
of warranty, government seizure, recall or similar claim for injury
to person or property or any other claim related to the Transferred
Assets or the Products, in each case to the extent arising prior to
the Closing (including all proceedings relating to any such
Liabilities);
(iv) any Liabilities of Seller with
respect to any litigation or other claims related to the
Transferred Assets or the Products to the extent arising from any
event, circumstance or condition occurring or alleged to have
occurred prior to the Closing;
(v) any Liability of Seller related
to any product, property, tangible or intangible, or service of
Seller not related to the Products;
(vi) any Liability of Seller arising
out of any actual or alleged violation by Seller or any of its
Affiliates of any Law applicable to Seller or any of its
Affiliates; and
4
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
(vii) any other Liability of Seller
resulting from the ownership, use, operation or maintenance of the
Transferred Assets by or on behalf of Seller prior to the
Closing.
SECTION 2.4
Consideration .
(a) Consideration . As
consideration for the Transferred Assets, Transferred Contracts and
rights granted to Purchaser hereunder:
(i) Purchaser shall assume the
Assumed Liabilities;
(ii) Purchaser shall pay to Seller
the sum of $10,000,000 by wire transfer of immediately available
funds at the Closing;
(iii) Purchaser shall pay to Seller
the Reimbursed Development Costs by wire transfer of immediately
available funds at the Closing;
(iv) Purchaser shall pay to Seller
the First Milestone Payment by wire transfer of immediately
available funds within ten (10) days of the First Milestone
Achievement Date;
(v) Purchaser shall pay to Seller
each applicable Additional Milestone Payment amount by wire
transfer of immediately available funds within ten (10) days
of each occurrence of the applicable Additional Milestone
Achievement Date; and
(vi) Purchaser shall pay to Seller
by wire transfer of immediately available funds the royalties as
set forth on Exhibit D .
(b) Transfer Taxes . Any
transfer, documentary, sales, use, valued-added, gross receipts,
stamp, registration or other similar transfer Taxes incurred in
connection with or as a consequence of the transfer and sale of the
Transferred Assets pursuant to this Agreement (“ Transfer
Taxes ”) shall be paid by Purchaser; provided, however,
that Seller shall properly pay over to the appropriate Governmental
Authority any Barbados stamp tax due and owing with respect to the
transactions contemplated by this Agreement and affix, or cause to
be affixed, the appropriate stamp as required under Barbados law to
any documents as required by Barbados law, and upon demonstration
to Purchaser that such Barbados stamp tax has been duly paid and
the stamp duly affixed, Purchaser shall reimburse Seller for the
amount of such Barbados stamp tax. The Parties hereto shall
cooperate, to the extent reasonably requested and legally
permitted, to reduce any such Transfer Taxes.
(c) Required Withholding .
Purchaser shall withhold and deduct from the consideration set
forth in Section 2.4(a) any amounts required to be withheld
and deducted from such consideration under the Code or other
applicable Law. Any amounts so withheld and deducted shall be
remitted by Purchaser on a timely basis to the appropriate
Governmental Authority for the account of Seller and Purchaser
shall provide Seller reasonable evidence of such remittance within
thirty (30) days of such remittance. To the extent that
amounts are so
5
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
withheld by Purchaser and duly paid over to the
appropriate Governmental Authority, such withheld amounts shall be
treated for all purposes of this Agreement as having been paid to
Seller in respect of which such deduction and withholding was made
by the Purchaser. Seller shall furnish to Purchaser such forms,
certificates and documentation (including, without limitation,
Internal Revenue Service Forms W-8 and W-9) as may be necessary or
appropriate, and that are legally required, to obtain any reduction
of, credit for, or exemption from any withholding.
(d) Allocation of Milestone and
Royalty Payments and Withholding Indemnity .
(i) The parties agree that the
Milestone Payments under section 2.4(a)(iv) and (v) and the
Royalties under section 2.4(a)(vi) have been allocated to the
following intangible assets according to (or based on) the relative
values of the assets purchased (to the extent such asset has value
in excess of what will be paid pursuant to the Assumed
Liabilities): (i) [*], (ii) [*], and (iv) [*]. The
parties agree to be bound by the following allocation for purposes
of the withholding tax documentation:
|
|
|
|
|
|
|
|
|
|
|
[*]
|
|
|
[*]
|
|
|
[*]
|
|
Milestone Payments
|
|
[*]
|
%
|
|
[*]
|
%
|
|
[*]
|
|
Pre-Patent Expiration Royalties
|
|
[*]
|
%
|
|
[*]
|
%
|
|
[*]
|
|
Post-Patent Expiration Royalties
|
|
[*]
|
%
|
|
[*]
|
%
|
|
[*]
|
(ii) Notwithstanding anything in
this Agreement to the contrary, Purchaser and Seller agree that, if
a Taxing authority successfully challenges the allocations agreed
to pursuant to paragraph (i) of this Section 2.4(d), and,
as a result of such challenge, such Taxing authority imposes
additional withholding taxes, or penalties or interest with respect
to withholding taxes, on any milestone or royalty payment made to
Seller under this Agreement, and such taxes, penalties or interest
are assessed against Purchaser or any of its Affiliates, Seller
shall indemnify and hold harmless Purchaser and any such Affiliate
from and against such taxes, penalties and interest and any other
damages related thereto. Payment on this indemnification shall be
made within thirty (30) days from the date Purchaser makes a
written demand therefor.
SECTION 2.5
Closing . Subject
to the terms and conditions of this Agreement, the closing of the
transactions contemplated by this Agreement (the “
Closing ”), including the transfer of the Transferred
Assets, shall be held at the offices of Cooley Godward Kronish LLP,
3175 Hanover Street, Palo Alto, California at 10:00 a.m. Pacific
Standard Time on June 11, 2009, contemporaneously with the
execution and delivery of this Agreement, or such later date as the
Parties agree upon in writing (the “ Closing Date
”).
6
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
SECTION 2.6 Closing Deliveries
by Seller . At the
Closing, Seller shall deliver or cause to be delivered to
Purchaser:
(a) an original of each Transaction
Document to which Seller is a party, duly executed by
Seller;
(b) the certificates and other
documents required to be delivered pursuant to
Section 6.2;
(c) all of the Transferred Assets
and other materials set forth on Exhibit B designated to be
delivered at the Closing, subject to Sections 2.2, 2.8 and 2.9;
and
(d) such other deeds, bills of sale,
assignments, certificates of title, documents and other instruments
of transfer and conveyance, as may reasonably be requested by
Purchaser, each in form and substance satisfactory to Purchaser and
its legal counsel and duly executed by Seller, as
applicable.
SECTION 2.7 Closing Deliveries
by Purchaser . At
the Closing, Purchaser shall deliver to Seller:
(a) an original of each Transaction
Document to which Purchaser is a party, duly executed by
Purchaser;
(b) the payments described in
Section 2.4(a)(ii), (iii), and, if applicable, (iv);
and
(c) the certificates and other
documents required to be delivered pursuant to
Section 6.1.
SECTION 2.8 Further Deliveries
by Seller . At or
promptly following the Closing, but in no event later than ten
(10) days thereafter, Seller shall deliver or cause to be
delivered to Purchaser, in the manner and form and to the
location(s) reasonably specified by Purchaser, at Seller’s
expense, the Transferred Assets listed on Exhibit B hereto
which were not delivered to Seller on the Closing Date. Seller
shall transfer and assign the Product NDA to Purchaser as set forth
in Section 5.1.
SECTION 2.9 Agreements
Relating to Electronic Transfer and Physical Delivery of
Transferred Assets .
(a) Delivery by Electronic
Transfer. Seller and Purchaser agree that any of the
Transferred Assets of the type that can be transmitted to Purchaser
electronically will be so delivered to Purchaser as soon as
reasonably practicable following the Closing and, if delivered
electronically, will not be delivered to Purchaser on any tangible
medium. Promptly following any electronic transmission, Seller
shall execute and deliver to Purchaser a written certificate
containing the following information: (a) the date of
transmission, (b) the time the transmission
7
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
was commenced and concluded, (c) the name
of the individual who made the transmission, (d) the signature
of such individual, (e) the security measures utilized to
protect such transmission from improper disclosure or corruption
and (f) a general description of the nature of the items
transmitted sufficient to distinguish the transmission from other
transmissions or deliveries.
(b) Physical Delivery of
Transferred Assets. Seller will make arrangements with its
usual third-party transporters for transport, promptly following
the Closing, of the Transferred Assets to be delivered at Closing
(except for those Transferred Assets to be delivered pursuant to
Sections 2.6, 2.8 and 2.9(a)), to Purchaser’s location or
other designated site. Purchaser shall bear the transport costs for
such Transferred Assets but the risk of loss with respect thereto
shall be borne by Seller until delivery has been made to Purchaser
or such site as Purchaser may designate.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF
SELLER
Except as set forth in the
disclosure schedule delivered by Seller to Purchaser and dated as
of the date hereof (the “ Seller Disclosure Schedule
”), which Seller Disclosure Schedule identifies the
Section (or, if applicable, subsection) of this Agreement or
the appropriate Exhibit to which such exception relates (provided,
however, that such disclosure shall also apply to particular
matters represented or warranted in other Sections and subsections
to the extent that it is readily apparent from the text of such
disclosure), Seller hereby represents and warrants to Purchaser, as
of the date of this Agreement and (if different) as of the Closing
Date, as set forth on Exhibit E , each of which
representations and warranties is true and correct and shall
survive the Closing as set forth herein.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF
PURCHASER
Except as set forth in the
disclosure schedule delivered by Purchaser to Seller and dated as
of the date hereof (the “ Purchaser Disclosure
Schedule ”), which Purchaser Disclosure
Schedule identifies the Section (or, if applicable,
subsection) of this Agreement or the appropriate Exhibit to which
such exception relates (provided, however, that such disclosure
shall also apply to particular matters represented or warranted in
other Sections and subsections to the extent that it is readily
apparent from the text of such disclosure), Purchaser hereby
represents and warrants to Seller, as of the date of this Agreement
and (if different) as of the Closing Date, as set forth on
Exhibit H , each of which representations and warranties is
true and correct and shall survive the Closing as set forth
herein.
8
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
ARTICLE V
ADDITIONAL
AGREEMENTS
SECTION 5.1 NDA Transfer
. Within three
(3) Business Days of Seller’s receipt of written notice
from the FDA that the Product NDA has been approved, Seller will
take all steps required under 21 C.F.R. 314.72 to assign and
transfer all of Seller’s rights in the Product NDA to
Purchaser and to notify the FDA of same. Prior to transfer and
assignment of Seller’s rights in the Product NDA to
Purchaser, Purchaser will be deemed to have a beneficial right and
interest in and to such Transferred Asset to the extent
contemplated herein, but legal title to such asset shall not be
deemed to have been passed to Purchaser until the occurrence of
such transfer and assignment. For the avoidance of doubt, for
purposes of Seller’s representations and warranties and other
obligations pursuant to this Agreement, the Product NDA shall not
be deemed a Transferred Asset as of any date or time period prior
to the assignment and transfer described in this
Section 5.1.
SECTION 5.2
Diligence .
(a) Generally. As a
substantial portion of Seller’s potential consideration for
the asset transfer under this Agreement is based on events
subsequent to the Effective Date, most of which events will depend
for achievement on efforts by Purchaser, the Parties agree that
Purchaser’s diligent efforts to achieve such events
successfully is a fundamental commitment of the deal agreed upon by
the Parties under this Agreement, and, therefore, Purchaser agrees
to use general commercial diligence as provided in subsection
(b) below.
(b) General Commercial
Efforts. Purchaser, directly or through its Affiliates,
Licensees and/or other contractors, shall use Commercially
Reasonable Efforts to develop (other than as to such development
efforts to be conducted by Seller under the Development and
Services Agreement) and to commercialize the Products in the
Territory. It is understood, however, that Purchaser will not be
required to continue to promote Products during any period in which
one or more Generic Versions of such Products are being
commercially marketed and sold in the Territory by any Third
Party.
SECTION 5.3
Audits .
(a) Audit Rights . Upon at
least thirty (30) days prior written notice from Seller and
not more than once per year, Purchaser shall permit, and shall
require its Affiliates to permit, Seller to have access during
normal business hours to such books of account and records of
Purchaser and its Affiliates, at the appropriate party’s
principal place of business, as may be reasonably necessary to
confirm that Purchaser is complying with its obligations under
Section 5.2.
9
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
SECTION 5.4
Confidentiality .
(a) Proprietary Information .
Except as otherwise provided in this Section 5.4, each Party
(the “ Receiving Party ”) shall maintain in
confidence and use only for purposes of this Agreement any
confidential information and data disclosed and materials supplied
to such Party by another Party (the “ Disclosing Party
”) under this Agreement or any other Transaction Document
(such information, data and materials, collectively “
Proprietary Information ”). For purposes of this
Section 5.4, (i) all “Confidential
Information” disclosed pursuant to the Non-Disclosure
Agreement, dated December 16, 2008, by and among Neuromed
Pharmaceuticals Ltd., a Canadian corporation (“ NPL
”), Neuromed Pharmaceuticals Inc., a Delaware corporation
(“ NPI ”), and Purchaser (the “ Prior
Agreement ”) shall be deemed Proprietary Information of
Seller (and hence Purchaser shall be considered the Receiving Party
with respect thereto) except to the extent it comprises Transferred
Assets and except as provided below, (ii) the Transferred
Assets shall be deemed Proprietary Information of Purchaser (and
hence Seller shall be considered the Receiving Party with respect
thereto), and (iii) subject to the understandings set forth in
clauses (i) and (ii) of the sentence, all disclosures
under the Prior Agreement shall be considered to be disclosures of
Proprietary Information protected by and to the extent set forth in
this Section 5.4, notwithstanding the mutual agreed
termination of the Prior Agreement by the Parties. For purposes of
the definitions of Receiving Party and Disclosing Party, Seller,
NPI and NPL shall be deemed a single Party. The obligations of the
Receiving Party under this Section 5.4 not to disclose or use
Proprietary Information of the other Party shall not apply,
however, to the extent that any such information, data or
materials:
(i) have been or are hereafter
published or otherwise become public, other than by acts or
omissions of the Receiving Party in breach of this
Agreement;
(ii) the Receiving Party can
demonstrate by competent evidence have been disclosed to the
Receiving Party by a Third Party that has the legal right to
disclose such information without breaching any known obligation of
confidentiality;
(iii) the Receiving Party can
demonstrate by competent evidence have been independently developed
by employees, agents or consultants of the Receiving Party without
use of the Disclosing Party’s Proprietary Information as
evidenced by the Receiving Party’s business records;
or
(iv) have been disclosed by the
Receiving Party with the prior written consent of the Disclosing
Party.
(b) Permitted Disclosures .
To the extent it is reasonably necessary or appropriate for a
Receiving Party to fulfill its obligations or exercise its rights
under this Agreement or any other Transaction Document:
(i) a Receiving Party may disclose
Proprietary Information of the other Party to the Receiving
Party’s Affiliates, licensees and prospective licensees,
employees, consultants, outside contractors, clinical investigators
and other Persons on a need-to-know basis
10
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
in accordance with the exercise of rights
granted to or retained by such Receiving Party under this Agreement
or any other Transaction Document, provided that such Persons agree
to be bound by obligations of confidentiality and non-use with
respect to such Proprietary Information consistent with those set
forth herein;
(ii) a Receiving Party may disclose
Proprietary Information of the other Party to government or other
regulatory authorities to the extent that such disclosure is
required by applicable Law, regulation or agency or court order,
provided that the Receiving Party shall (if legally possible under
the circumstances) provide reasonable advance notice to the other
Party and cooperate with such Disclosing Party (at the Disclosing
Party’s expense) to allow the Disclosing Party to oppose such
disclosure or to request confidential treatment of such Proprietary
Information; and
(iii) Seller may disclose to the FDA
the Proprietary Information of Purchaser related to the Products in
connection with the Product NDA and Seller’s obligations
pursuant to the Development and Transition Services
Agreement.
(c) Nondisclosure of Terms; Press
Release . Each Party agrees not to disclose the terms of this
Agreement or any other Transaction Document to any Third Party
without the prior written consent of the other Party, except:
(i) to such Party’s advisors (including financial
advisors, attorneys and accountants), potential and existing
investors and others on a need-to-know basis, in each case under
confidentiality obligations and provided that such Party covenants
to use commercially reasonable efforts to make such confidentiality
obligations associated with such disclosure as stringent as
practicable, (ii) potential or actual acquirers or purchasers
of such Party, or of such Party’s stock or any relevant
portion of such Party’s assets, or potential or actual
licensees or sublicensees, in each case under confidentiality
obligations and provided that such Party covenants to use
commercially reasonably efforts to make such confidentiality
obligations associated with such disclosure as stringent as
practicable, or (iii) to the extent necessary to comply with
applicable Law, regulations, the directives of any Governmental
Authority or any court order, provided that the Party required to
make such disclosure shall promptly notify the other Party (if
legally possible under the circumstances) and allow such other
Party a reasonable time to oppose such disclosure and/or to seek
limitations on the portion of this Agreement required to be
disclosed. Notwithstanding the foregoing, subject to any required
approval by ALZA as set forth in the Transferred Contracts, Seller
and Purchaser (or their appropriate Affiliates) may each issue a
press release to announce the execution of this Agreement in a form
reasonably acceptable to each other and, following the issuance of
such press releases, Purchaser and Seller may each disclose to
Third Parties the information contained in such press release
without the need for further approval by the other.
(d) The Parties hereby agree that
the obligations set forth in this Section 5.4 shall remain in
effect until the tenth anniversary of the Closing Date.
(e) Each Party agrees that any
breach by it of any of its obligations set forth in this
Section 5.4 may cause irreparable harm to the other Party for
which monetary damages may
11
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
neither be adequate nor readily calculable and,
therefore, in the event of any such breach by a Party of this
Section 5.4, the other Party shall have the right to seek an
injunction or any other appropriate equitable remedy without the
necessity of posting a bond or other form of financial assurance
and in addition to seeking any monetary damages that may be
available to redress such breach.
SECTION 5.5 Tax Matters
.
(a) Responsibility for Taxes and
Tax Matters .
(i) Seller will be responsible for
the preparation and filing of all Tax Returns of Seller (including
Tax Returns required to be filed after the Closing Date) to the
extent such Tax Returns include or relate to Seller’s use or
ownership of the Transferred Assets attributable to the Pre-Closing
Tax Period. Seller’s Tax Returns, to the extent they relate
in any manner to the Transferred Assets or the transactions
contemplated herein, shall be true, complete and correct in all
material respects and prepared in accordance with applicable Law.
Seller will be responsible for and make all payments of Taxes shown
to be due on such Tax Returns to the extent they relate to the
Transferred Assets.
(ii) Purchaser or Purchaser’s
Affiliates will be responsible for the preparation and filing of
all Tax Returns they are required to file with respect to
Purchaser’s ownership or use of the Transferred Assets
attributable to the Post-Closing Tax Period. Purchaser’s or
its Affiliates’ Tax Returns, to the extent they relate to the
Transferred Assets or the transactions contemplated herein, shall
be true, complete and correct in all material respects and prepared
in accordance with applicable Law. Purchaser will be responsible
for and make all payments of Taxes shown to be due on such Tax
Returns to the extent they relate to the Transferred
Assets.
(b) Prior Tax Agreements .
Seller shall terminate any and all of the Tax sharing, allocation,
indemnification or similar agreements, arrangements or undertakings
in effect, written or unwritten, on the Closing Date as between
Seller and any other party under which Purchaser or the Transferred
Assets could be liable for any Taxes or other claims of any
party.
(c) Cooperation . To the
extent relevant to the Transferred Assets, each Party shall
(i) provide the other with such assistance as may reasonably
be required in connection with the preparation of any Tax Return,
any amended Tax Return or any claim for refund, the determination
of a Liability for Taxes or a right to refund Taxes, and the
conduct of any audit or other examination by any taxing authority
or in connection with judicial or administrative proceedings
relating to any liability for Taxes and (ii) retain and
provide the other with all records or other information that may be
relevant to the preparation of any Tax Returns, or the conduct of
any audit or examination or other proceeding relating to Taxes.
Such cooperation and information shall include providing copies of
all relevant Tax Returns relating to any involved non-income Taxes,
together with accompanying schedules and related work papers,
documents
12
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
relating to rulings or other determinations by
any Governmental Authority. Seller shall retain all documents,
including prior years’ Tax Returns, supporting work schedules
and other records or information with respect to all sales, use and
employment Tax Returns and, absent the receipt by Seller of the
relevant tax clearance certificates, shall not destroy or otherwise
dispose of any such records for six (6) years after Closing
without the prior written consent of Purchaser. Purchaser and
Seller shall make their employees available to each other on a
mutually convenient basis to provide explanation of any documents
or information provided hereunder. Notwithstanding the foregoing,
neither Purchaser nor Seller shall be required to prepare any
documents, or determine any information not then in their
possession in response to a request under this Section 5.5(c).
Purchaser and Seller shall reimburse each other for any reasonable
out-of-pocket costs incurred by the other in providing any Tax
Return, document or other written information, and shall reimburse
the other for any reasonable out-of-pocket expenses upon receipt of
reasonable documentation of such costs. Any information obtained
under this Section 5.5(c) shall be kept confidential, except
as may be otherwise necessary in connection with the filing of Tax
Returns or claims for refund or in conducting any Tax audit or Tax
controversy proceeding.
(d) Withholding Taxes Resulting
From Purchaser Action . If Purchaser is required to make a
payment to Seller subject to a deduction or withholding of Tax,
then (A) if such deduction or withholding of Tax obligation
arises as a result of any action taken by Purchaser, including an
assignment of all or any portion of this Agreement or any rights or
obligations hereunder to an Affiliate or successor of Purchaser but
excluding any other transaction expressly contemplated by this
Agreement, and such action has the effect of increasing the amount
of Tax deducted or withheld (a “ Purchaser Withholding Tax
Action ”), then notwithstanding Section 2.4(c), the
payment by Purchaser (in respect of which such deduction or
withholding of Tax is required to be made) shall be increased by
the amount necessary (the “ Additional Tax ”) to
ensure that Seller receives an amount equal to the same amount that
it would have received had no Purchaser Withholding Tax Action
occurred, and (B) the Additional Tax shall be deducted and
withheld by Purchaser from the payment made by Purchaser to Seller.
The Additional Tax, along with any other Tax deducted and withheld
from the payment made by Purchaser, shall be timely remitted to the
proper Governmental Authority for the account of Seller in
accordance with applicable Law and Purchaser shall provide Seller
reasonable evidence of such remittance within 30 days of such
remittance.
SECTION 5.6 Regulatory
Matters . Purchaser
acknowledges that, except as set forth in the Development and
Transition Services Agreement, Purchaser and its Affiliates will be
responsible for obtaining and maintaining the federal and state
permits and licenses required in order for Purchaser and its
Affiliates to use the Transferred Assets after the Closing, and,
except for any obligation expressly set forth in this Agreement and
the Development and Transition Services Agreement, that Seller will
not have duties or obligations to Purchaser with respect to any
such permits and licenses.
SECTION 5.7 Royalty-Related
Rights and Obligations . The Parties agree to be bound by the terms and
conditions of Exhibit D .
13
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
SECTION 5.8 Further
Assurance . On and
after the Closing Date, Seller shall from time to time, at the
reasonable request of Purchaser, execute, acknowledge and deliver,
or cause to be executed, acknowledged and delivered, such further
conveyances, notices and assumptions and such other instruments,
and take such other actions, as Purchaser may reasonably request in
order to more effectively consummate the transactions contemplated
hereby and to transfer fully to Purchaser good and marketable title
to the Transferred Assets and all of the titles, rights, interests,
remedies, powers and privileges intended to be conveyed under the
Transaction Documents (including assistance in the collection or
reduction to possession of any of the Transferred Assets). On and
after the Closing Date, Purchaser shall from time to time, at the
reasonable request of Seller, execute, acknowledge and deliver, or
cause to be executed, acknowledged and delivered, such further
notices and assumptions and such other instruments, and take such
other actions, as Seller may reasonably request in order to more
effectively consummate the transactions contemplated hereby and to
transfer fully to Purchaser the Assumed Liabilities.
ARTICLE VI
CONDITIONS TO
CLOSING
SECTION 6.1 Conditions to
Obligations of Seller . The obligation of Seller to effect the Closing
is subject to the satisfaction, at or prior to the Closing, of each
of the following conditions (any of which may be waived by Seller
in whole or in part):
(a) Representations, Warranties
and Covenants . The representations and warranties of Purchaser
contained in this Agreement shall be true and correct in all
respects as of the Closing Date. Purchaser shall have performed all
agreements and covenants required by this Agreement to be performed
by it prior to or on the Closing Date. Seller shall have received a
certificate as to satisfaction of the conditions set forth in this
Section 6.1(a) dated as of the Closing Date and executed by a
duly authorized officer of Purchaser.
(b) No Actions or Proceedings
. No Action shall be pending or threatened by or before any
Governmental Authority challenging or seeking to make illegal, to
materially delay or otherwise to restrain or prohibit the
consummation of the transactions contemplated by this
Agreement.
(c) Resolutions of Purchaser
. Seller shall have received a true and complete copy, certified by
the Secretary or an Assistant Secretary of Purchaser, of the
resolutions duly and validly adopted by the board of directors of
Purchaser evidencing its authorization of the execution and
delivery by Purchaser of the Transaction Documents and the
consummation of the transactions contemplated by this
Agreement.
(d) Consents and Approvals .
Purchaser and Seller shall have received, each in form and
substance satisfactory to Seller in its reasonable discretion, all
Consents that Seller in
14
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
its reasonable discretion deems necessary or
desirable for the consummation of the transactions contemplated by
this Agreement.
(e) Documents . Seller shall
have received from Purchaser all of the documents and agreements
set forth in Section 2.7.
(f) Guaranty . Seller shall
have received from Covidien International Finance S.A. a guaranty
of the performance by Purchaser of its obligations under this
Agreement and the Transaction Documents, in the form attached
hereto as Exhibit L .
SECTION 6.2 Conditions to
Obligations of Purchaser . The obligation of Purchaser to effect the
Closing is subject to the satisfaction, at or prior to the Closing,
of each of the following conditions (any of which may be waived by
Purchaser in whole or in part):
(a) Representations, Warranties
and Covenants . The representations and warranties of Seller
contained in this Agreement shall be true and correct in all
respects as of the Closing Date. Seller shall have performed all
agreements and covenants required by this Agreement to be performed
by it prior to or on the Closing Date. Purchaser shall have
received a certificate as to satisfaction of the conditions set
forth in this Section 6.2(a) dated as of the Closing Date and
executed by a duly authorized director of Seller.
(b) No Actions or Proceedings
. No Action shall be pending or threatened by or before any
Governmental Authority challenging or seeking to make illegal, to
materially delay or otherwise to restrain or prohibit the
consummation of the transactions contemplated by this
Agreement.
(c) Resolutions of Seller .
Purchaser shall have received a true and complete copy, certified
by the Secretary or an Assistant Secretary of Seller, of the
resolutions duly and validly adopted by the board of directors of
Seller evidencing its authorization of the execution and delivery
of the Transaction Documents and the consummation of the
transactions contemplated by this Agreement.
(d) Consents and Approvals .
Purchaser and Seller shall have received, each in form and
substance satisfactory to Purchaser in its reasonable discretion,
all (i) Consents that Purchaser in its reasonable discretion
deems necessary or desirable for the consummation of the
transactions contemplated by this Agreement and (ii) all
consents of Third Parties set forth on Schedule 6.2(d)
hereto.
(e) Documents . Purchaser
shall have received from Seller all of the documents, agreements
and other Transferred Assets set forth in
Section 2.6.
(f) Guaranty . Purchaser
shall have received from NPL a guaranty of the performance by
Seller of its obligations under this Agreement and the Transaction
Documents, in the form attached hereto as Exhibit M
.
15
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
ARTICLE VII
INDEMNIFICATION
SECTION 7.1 Survival of
Representations and Warranties and Covenants
. Any claims regarding the
representations and warranties of Purchaser and Seller contained in
this Agreement shall survive the Closing (with respect to any given
representation and warranty, the “ Survival Period
”) for a period of eighteen (18) months, unless
otherwise expressly provided for in this Agreement; provided that,
(i) the Survival Period for the representations and warranties
of Seller set forth in Sections 2 (the first sentence only), 4(b)
(first sentence only), 4(d), 8 and 9 of Exhibit E and
(ii) the representations and warranties of Purchaser set forth
in Sections 2 and 3 of Exhibit H shall be indefinite; and
provided further that, the Survival Period for the representations
and warranties of Seller set forth in Section 7 of Exhibit
E shall be the period of any applicable statute of limitations
plus sixty (60) days. The covenants and agreements contained
herein shall survive following the Closing in accordance with their
respective terms. Following the expiration of the applicable
Survival Period, no Party shall make any claim for, or be subject
to any Liabilities in respect of, any breach of such
representations and warranties (except with respect to claims for
indemnification for Third Party Claims for which written notice of
such claim, pursuant to Section 7.2(c)(i), has been given
prior to the expiration of the Survival Period).
SECTION 7.2
Indemnification .
(a) Indemnification by Seller
. Seller shall indemnify and hold harmless Purchaser and its
Affiliates and its and their officers, directors, employees,
agents, successors and assigns (each, a “ Purchaser
Indemnified Party ”) from and against any and all
liabilities, losses, damages, costs and expenses, interest, awards,
judgments and penalties, (including reasonable attorneys’
fees and expenses associated therewith and any of the foregoing
that may result from any Third Party Claims) (collectively, “
Losses ”) suffered or incurred by any Purchaser
Indemnified Party arising out of or resulting from the
following:
(i) the breach of any representation
or warranty made by Seller contained in this Agreement,
(ii) the breach of any covenant or
agreement by Seller contained in this Agreement, and
(iii) the Retained Liabilities
solely to the extent that such Losses are directly incurred by
Purchaser as a result of (A) Third Party Claims made against a
Purchaser Indemnified Party with respect to such Retained Liability
or (B) Purchaser’s fulfillment of Seller’s
obligations under any Retained Liability in the event that such
fulfillment is reasonably required for Purchaser to maintain or
exercise the rights granted to it under this Agreement, provided,
however, the limitations set forth in this Section 7.2(a)(iii)
shall not apply to Losses related to Taxes.
16
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
(b) Indemnification by
Purchaser . Except as and to the extent due to any act or
omission to act by Seller or its Affiliates that is in breach of
any representation, warranty, covenant or agreement set forth
herein or in any of the Transaction Documents, Purchaser shall
indemnify and hold harmless Seller and its Affiliates, and its and
their officers, directors, employees, agents, successors and
assigns (each a “ Seller Indemnified Party ”)
from and against any and all Losses suffered or incurred by them
arising out of or resulting from the following:
(i) the breach of any representation
or warranty made by the Purchaser contained in this
Agreement,
(ii) the breach of any covenant or
agreement by Purchaser contained in this Agreement,
(iii) the Assumed
Liabilities,
(iv) the use, possession or
ownership of the Transferred Assets by or on behalf of the
Purchaser or its Affiliates or Licensees,
(v) the performance, or breach or
failure to perform, by Purchaser of its obligations or covenants
under the Transferred Contracts, and
(vi) the research, development,
manufacture, distribution, use, testing, promotion, marketing, or
sale or other disposition of Products by or on behalf of the
Purchaser or its Affiliates or Licensees.
(c) Indemnification Procedure
.
(i) Whenever any Loss is asserted
against or incurred by a Purchaser Indemnified Party or Seller
Indemnified Party (the “ Indemnified Party ”)
which the Indemnified Party has determined has given or could give
rise to a right of indemnification under this Agreement, the
Indemnified Party will give written notice thereof (a “
Claim ”) to the other Party (the “
Indemnifying Party ”). The Indemnified Party will
furnish to the Indemnifying Party in reasonable detail such
information as the Indemnified Party may have with respect to the
Claim. The failure to give such notice will not relieve the
Indemnifying Party of its indemnification obligations under this
Agreement, unless the failure to give such notice is materially
prejudicial to an Indemnifying Party’s ability to defend any
Third Party Claim which forms the basis for
indemnification.
(ii) Within thirty (30) days
after delivery of such notice, the Indemnifying Party may, upon
written notice thereof to the Indemnified Party, and at its
expense, undertake the defense of such Third Party Claim with
attorneys of its own choosing; provided, that the Indemnifying
Party shall not be entitled to undertake the defense of any Third
Party Claim related to Taxes. In the event that the Indemnifying
Party does not assume control of such defense, the Indemnified
Party may undertake the defense of such Third Party Claim at the
expense of the Indemnifying Party.
17
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
(iii) The Party not controlling the
defense of a Third Party Claim may participate therein at its own
expense, provided, that if the Indemnifying Party assumes control
of such defense and the Indemnified Party reasonably concludes,
based on advice from counsel, that the Indemnifying Party and the
Indemnified Party have conflicting interests with respect to such
action, suit, proceeding or claim, the Indemnifying Party will be
responsible for the reasonable fees and expenses of counsel to the
Indemnified Party solely in connection therewith, provided further,
however, that in no event will the Indemnifying Party be
responsible for the fees and expenses of more than one counsel in
any one jurisdiction for all Indemnified Parties.
(iv) The Party controlling the
defense of a Third Party Claim will keep the other Party advised of
the status of such action, suit, proceeding or claim and the
defense thereof and will consider recommendations made by the other
Party with respect thereto. As reasonably requested by, and at the
expense of, the Party controlling such defense, the other Party
will cooperate in such defense and make available to the Party
controlling such defense all witnesses, pertinent records,
materials and information in such other Party’s possession or
under such other Party’s control relating thereto.
(v) The Indemnified Party will not
agree to any settlement of any action, suit, proceeding or claim
without the prior written consent of the Indemnifying Party, which
will not be unreasonably withheld or delayed. The Indemnifying
Party will not consent to entry of any judgment or enter into any
settlement that admits fault on the part of the Indemnified Party
or that does not grant to the Indemnified Party an unconditional
release of all relevant claims with no continuing obligations or
restrictions on the part of the Indemnified Party, except with the
prior written consent of the Indemnified Party, which consent will
not be unreasonably withheld or delayed. In the event that the
Indemnified Party refuses to consent to the entry of a judgment or
a settlement for which the Indemnifying Party is solely and
entirely responsible and for which the payment of monetary damages
is the sole remedy, following such refusal, the liability of the
Indemnifying Party to the Indemnified Party will be fixed at the
amount of any money damages provided in the proposed judgment or
settlement.
(d) Limitations on
Indemnification .
(i) The indemnification provided in
this Article VII shall be the sole and exclusive remedy of the
Parties after the Closing for monetary damages for Claims;
provided, however, this exclusive remedy for damages does not
preclude a Party from bringing an action for (A) fraud or
(B) specific performance or other equitable remedy to require
a Party to perform its obligations under this Agreement.
(ii) Notwithstanding anything to the
contrary herein, except for Losses arising from fraud, the
aggregate Liability of Seller under this Article VII for Losses
arising from or attributable to any breach of the representation
and warranties and covenants made by Seller in this Agreement or
any certificate or other instrument delivered by Seller pursuant to
this Agreement (other than the Development and Transition Services
Agreement) shall be limited to $10,000,000; provided, however, the
foregoing limitation shall not apply to Losses related
to
18
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
Taxes, and provided further that for Losses
resulting from breach of Seller’s warranty in
Section 4(e) of Exhibit E of this Agreement, the foregoing
limit shall not apply and instead the limit for such Losses shall
be the lesser of (A) $30,000,000, or (B) the actual
aggregate amount of any milestone payments made to Seller (through
the date of termination by ALZA Corporation, hereinafter
“ALZA”, that gives rise to Seller’s breach of
such warranty) pursuant to Section 2.4(a)(iv) and
Section 2.4(a)(v) plus the amount to be paid to Seller
pursuant to Section 2.4(a)(ii).
(iii) UNDER NO CIRCUMSTANCES WILL A
PARTY BE LIABLE TO THE OTHER PARTY FOR LOST PROFITS, LOST
OPPORTUNITIES, OR ANY OTHER PUNITIVE, SPECIAL, OR CONSEQUENTIAL
DAMAGES IRRESPECTIVE OF THE THEORY UNDER WHICH SUCH ACTION IS
BROUGHT, WHETHER IT WAS CAUSED OR ALLEGEDLY CAUSED BY THE
NEGLIGENCE OF SUCH PARTY OR WHETHER OR NOT SUCH PARTY HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, EXCEPT, NOTWITHSTANDING
THE FOREGOING, NOTHING IN THIS SECTION 7.2(d)(iii) SHALL LIMIT OR
RESTRICT A PARTY’S INDEMNIFICATION OBLIGATION OR LIABILITY
FOR LOSSES WITH RESPECT TO THIRD PARTY CLAIMS PURSUANT TO THIS
ARTICLE VII.
(e) Adjustment to Purchase
Price . Any indemnification payment made pursuant to this
Agreement shall be treated as an adjustment to the consideration
set forth in Section 2.4(a) for Tax purposes.
(f) If ALZA terminates the ALZA
Development and Commercialization Agreement (as defined in Exhibit
C of this Agreement) due specifically to the uncured breach or
default by Purchaser or Purchaser’s Affiliate or Licensee
occurring after the Effective Date in the performance or observance
of any of the material obligations (including diligence
obligations) under such ALZA Development and Commercialization
Agreement, then (in addition to any indemnification obligation
Purchaser may have under Section 7.2(b) for any Losses of
Seller resulting from such termination) Purchaser shall pay to
Seller all amounts of royalties paid to Purchaser (or its
Affiliate) by ALZA under Section 12.5(c)(i) of the ALZA
Development and Commercialization Agreement after such termination
(such payments to be made within thirty (30) days of receipt
of the applicable royalty payments by ALZA); provided, that the
foregoing payments shall be reduced by the following percentage
amounts, if the ALZA termination occurs in the specified amount of
time after first commercial sale by Purchaser (or its Affiliate or
Licensee) of Product in the Territory: (w) [*]% if after one
year after such launch; (x) [*]% if after two years after such
launch; (y) [*]% if after three years after such launch; or
(z) [*]% [*] if such ALZA termination occurs after four years
after such launch.
19
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
ARTICLE VIII
MISCELLANEOUS
SECTION 8.1 Governing
Law. This Agreement
shall be governed by and construed in accordance with the laws of
the State of New York, without giving effect to any conflicts of
laws provisions or principles that would require application of
other law.
SECTION 8.2 Venue
.
(a) Any proceeding relating to this
Agreement or the enforcement of any provision of this Agreement
shall be brought or otherwise commenced in the United States
District Court for the Southern District of New York and, if such
court does not have subject matter jurisdiction, in a New York
State court of appropriate jurisdiction located within any portion
of the Southern District of New York. Each Party to this
Agreement:
(i) expressly and irrevocably
consents and submits to the non-exclusive jurisdiction of each
state and federal court (as appropriate) located in the Southern
District of New York (and each appellate court with respect to such
court) in connection with any such Proceeding,
(ii) agrees that each state and
federal court (as appropriate) located in the Southern District of
New York shall be deemed to be a convenient forum, and
(iii) agrees not to assert (by way
of motion, as a defense or otherwise), in any such proceeding
commenced in any state or federal court (as appropriate) located in
the Southern District of New York, any claim that such Party is not
subject personally to the jurisdiction of such court, that such
proceeding has been brought in an inconvenient forum, that the
venue of such proceeding is improper or that this Agreement or the
subject matter of this Agreement may not be enforced in or by such
court (unless it is unambiguously clear that such court does not
have appropriate subject matter jurisdiction).
(b) Notwithstanding subsection
(a) set forth immediately above, the Parties agree that if any
proceeding is commenced against any Indemnified Party by any Third
Party in or before any court or other tribunal anywhere in the
world, then such Indemnified Party may proceed against the such
Party in or before such court or other tribunal with respect to any
indemnification claim or other claim arising from or relating to
such proceeding or any of the matters alleged therein or any of the
circumstances giving rise thereto.
SECTION 8.3
Amendment . This
Agreement may not be amended, modified or supplemented except by an
instrument in writing signed by appropriate and duly authorized
representatives of Seller and Purchaser.
SECTION 8.4
Expenses . All
costs and expenses, including, without limitation, fees and
disbursements of counsel, financial advisors and accountants,
incurred in connection with
20
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
this Agreement and the Transactions contemplated
hereby shall be paid by the Party incurring such costs and
expenses, whether or not the Closing shall have
occurred.
SECTION 8.5
Notices . All
notices and other communications hereunder shall be in writing and
shall be deemed given if delivered personally or by commercial
messenger or courier service, mailed by registered or certified
mail (return receipt requested) or sent via facsimile (with
acknowledgment of complete transmission) to the Parties at the
following addresses (or at such other address for a Party as shall
be specified by like notice), provided, however, that notices sent
by mail shall not be deemed given until received:
21
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
If to Purchaser, to:
Covidien
675 McDonnell Blvd.
Hazelwood, MO 63042
Attn: Charles Bramlage
President,
Pharmaceutical Products/Imaging
(314) 654-6220 –
telephone
(314) 654-6020 –
facsimile
with copies (which shall not
constitute notice) to:
Covidien
675 McDonnell Blvd.
Hazelwood, MO 63042
Attn: C. Stephen Kriegh
Vice
President, Legal
(314) 654-6040 –
telephone
(314) 654-7181 –
facsimile
Covidien
15 Hampshire Street
Mansfield, MA 02048
Attn: Matthew J.
Nicolella
Vice
President – Chief Mergers & Acquisitions/Licensing
Counsel
(508) 261-8044 –
telephone
(508) 261-8544 –
facsimile
If to Seller, to:
Neuromed Development Inc.
Parker House, Wildey Business
Park
Wildey Road
St. Michael, BB14006
Barbados
Attention: Gillian Clark
Facsimile No.:
(246) 436-9812
with copies (which shall not
constitute notice) to:
Neuromed Pharmaceuticals
Ltd.
301-2389 Health Sciences
Mall
Vancouver, BC V6T1Z3
22
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
Canada
Attention: Christopher
Gallen
and
Cooley Godward Kronish
LLP
Five Palo Alto Square
Palo Alto, CA 94306
Attention: Barclay James
Kamb
Laura
A. Berezin
Facsimile No.:
(650) 849-7400
SECTION 8.6
Severability . In
the event that any provision of this Agreement or the application
thereof becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, the remainder of this
Agreement shall continue in full force and effect and the
application of such provision to other persons or circumstances
shall be interpreted so as reasonably to effect the intent of the
Parties. The Parties further agree to replace such void or
unenforceable provision of this Agreement with a valid and
enforceable provision that will achieve, to the extent possible,
the economic, business and other purposes of such void or
unenforceable provision.
SECTION 8.7 Entire
Agreement . This
Agreement, along with the other Transaction Documents and
instruments delivered in connection herewith, constitutes the
entire agreement of the Parties with respect to the subject matter
hereof and supersedes all prior agreements, representations,
undertakings and understandings, both written and oral, between
Seller and Purchaser with respect to the subject matter
hereof.
SECTION 8.8
Assignment .
Subject to this Section 8.8, this Agreement shall not be
assignable by any Party to any Third Party without the prior
written consent of the other Party. Notwithstanding the foregoing,
a Party may assign this Agreement, without the written consent of
the other Party, (a) to an Affiliate, provided that the
assigning Party guarantees the performance of this Agreement by
such Affiliate, or (b) to a successor to all or substantially
all of such assigning Party’s stock or the relevant portion
of its assets or business to which this Agreement relates (whether
by stock purchase, asset purchase, merger or otherwise), provided
that any such assignee agrees in writing to be bound by the terms
of this Agreement. In addition, Seller may assign its right to
receive payment hereunder to any Third Party with the consent of
Purchaser (not to be unreasonably withheld), and provided, that any
such assignee of the right to receive payment hereunder shall not
have the power or right to assert any of the rights of Seller
hereunder against Purchaser or any of its Affiliates. Any
assignment of this Agreement in contravention of this
Section 8.8 shall be null and void.
SECTION 8.9 Delays or
Omissions . Except as
expressly provided herein, no delay or omission to exercise any
right, power or remedy accruing to any Party to this Agreement upon
any breach or default of the other Party under this Agreement shall
impair any such right, power
23
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
or remedy of such non-defaulting Party, nor
shall it be construed to be a waiver of any such breach or default,
or an acquiescence therein, or a waiver or acquiescence with
respect to any similar breach or default thereafter occurring, nor
shall any waiver of any single breach or default be deemed a waiver
of any other breach or default theretofore or thereafter occurring.
Any waiver, permit, consent or approval of any kind or character on
the part of any Party of any breach or default under this
Agreement, or any waiver on the part of any Party of any provisions
or conditions of this Agreement, must be in writing and shall be
effective only to the extent specifically set forth in such
writing. All remedies, either under this Agreement or by law or
otherwise afforded to any Party to this Agreement, shall be
cumulative and not alternative.
SECTION 8.10 No Third Party
Beneficiaries . This
Agreement shall be binding upon and inure solely to the benefit of
the Parties and their permitted successors and assigns, and nothing
herein, express or implied, is intended to or shall confer upon any
other Person any legal or equitable right, benefit or remedy of any
nature whatsoever under or by reason of this Agreement.
SECTION 8.11
Counterparts .
This Agreement may be executed in counterparts, all of which
together shall constitute one and the same instrument.
SECTION 8.12 Specific
Performance . Each of
the Parties acknowledges and agrees that the other Party may be
damaged irreparably in the event any of the provisions of this
Agreement are not performed in accordance with their specific terms
or otherwise are breached or violated. Accordingly, each of the
Parties agrees that, without posting bond or other undertaking, the
other Parties will be entitled to seek an injunction or injunctions
to prevent breaches or violations of the provisions of this
Agreement and to enforce specifically this Agreement and the terms
and provisions hereof in any proceeding instituted in any court of
the United States or any state thereof having jurisdiction over the
Parties and the matter in addition to any other remedy to which it
may be entitled, at law or in equity. Each Party further agrees
that, in the event of any action for specific performance in
respect of such breach or violation, it will not assert that the
defense that a remedy at law would be adequate.
SECTION 8.13 WAIVER OF JURY
TRIAL . EACH PARTY
HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY
LITIGATION AS BETWEEN THE PARTIES DIRECTLY OR INDIRECTLY ARISING
OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY OR DISPUTES RELATING HERETO. EACH
PARTY HERETO (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR
ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II)
ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN
THIS SECTION 8.13 .
24
Portions of this Exhibit were
omitted and have been filed separately with the Secretary of the
Commission pursuant to the Company’s application requesting
confidential treatment under Rule 406 promulgated under the
Securities Act of 1933, as amended; [*] denotes
omissions.
In witness whereof, the Parties
hereto have caused this Agreement to be executed as of the date
first written above by their respective duly authorized
officers.
MALLINCKRODT INC.
|
|
|
|
By: /s/ John
H. Masterson
|
|
Witnessed this
11 th
day of June, 2009
|
|
|
|
Name: John
H. Masterson
|
|
By: /s/
Suzanne
|